Inventurus Knowledge Solutions Ltd

Inventurus Knowledge Solutions has allotted 4,70,000 equity shares under the IKS ESOP Plan on 04 December 2025.Powered by Capital Market - Live

Inventurus Knowledge Solutions announced the inauguration of its new office in Coimbatore today. The 1000-seat, state-of-the-art facility is designed to accommodate the rapid expansion of IKS Health's operations for the US Healthcare market. This new office is slated to become a significant talent hub, generating employment for recent university graduates, as well as experienced professionals with backgrounds in medicine, pharmacy, technology, and engineering. Nithya Balasubramanian, Whole-time Director & CFO, IKS Health said, 'Our second quarter performance for Fiscal Year 2026 demonstrates our commitment to consistent, profitable growth, evidenced by a 22% year-over-year growth in revenue, and a 60% rise in Profit After Tax (PAT). This sustained momentum is fundamentally driven by our talented workforce. The strategic expansion of our local talent base in Coimbatore is crucial, as it enhances our capacity for execution excellence and allows us to vigorously pursue our long-term objectives of enabling better, safer healthcare in the US market.' Powered by Capital Market - Live

Profit before tax (PBT) climbed 58.5% YoY to Rs 227.71 crore in Q2 FY26. EBITDA stood at Rs 271.8 crore, up 43% compared with Rs 189.8 crore posted in corresponding quarter last year. EBITDA margin improved to 34.8% in Q2 FY26 as against 29.5% in Q2 FY25. Sachin K. Gupta, Founder & Global CEO, IKS Health, said, 'The second quarter was a period of significant strategic execution and strong financial performance for IKS Health. Our results underscore the growing market demand for our Care Enablement Platform as health systems increasingly recognize the need to holistically address administrative, clinical, and financial challenges. A key highlight of this quarter was the launch of our Agentic AI platform on Google Cloud and native integration of Scribble Now, our ambient AI scribing solution, into revenue cycle management, coding, and clinical documentation workflows, creating the industry's first connected encounter-to-reimbursement platform and winning the 2025 Dora Award from Google Cloud Award for 'Augmenting Human Expertise with AI'. We have also significantly accelerated the execution of our AI strategy, marked by the appointment of our new Chief AI Officer. These accomplishments reflect our unwavering commitment to augmenting human expertise to deliver unparalleled clinical, financial, and operational excellence to our clients. Nithya Balasubramanian, Group CFO, IKS Health said, 'IKS Health's strong Q2 FY26 financial performance, highlighted by a 22% year-over-year Revenue, 43% EBITDA and 60% PAT growth reflects our continued focus on driving consistent, profitable growth. The improvement in our EBITDA margin showcases the scalability of our platform and disciplined capital management. ' Inventurus Knowledge Solutions (IKS Health) is a leading technology enabled healthcare solutions provider, primarily serving the US healthcare market. It offers a comprehensive care enablement platform that supports healthcare enterprises across outpatient and inpatient care settings.Powered by Capital Market - Live

Net profit of Inventurus Knowledge Solutions rose 59.93% to Rs 180.72 crore in the quarter ended September 2025 as against Rs 113.00 crore during the previous quarter ended September 2024. Sales rose 21.52% to Rs 781.09 crore in the quarter ended September 2025 as against Rs 642.78 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales781.09642.78 22 OPM %34.6129.42 - PBDT257.85172.03 50 PBT227.71143.70 58 NP180.72113.00 60 Powered by Capital Market - Live

Inventurus Knowledge Solutions has made further investment of USD 10,001,605/- in Inventurus Knowledge Solutions, Inc. (IKS Inc), a wholly owned subsidiary of the Company. Powered by Capital Market - Live

Inventurus Knowledge Solutions has granted 90,000 stock options under ESOP. Powered by Capital Market - Live

Inventurus Knowledge Solutions (IKS) has issued a statement to clarify its position regarding the recently announced changes to the H-1B visa fee structure. IKS confirms that the introduction of the $100,000 fee for new H-1B visa applications has no impact on its business operations or financial projections, as the company does not depend on H-1B visa holders for its workforce. The strategic business model is centered on delivering high-quality, scalable solutions through a robust delivery framework that combines proprietary technology, a highly skilled workforce in India, and a strong commitment to local hiring in the United States. H-1B visas are not integral to the execution of our core business operations or client service delivery. Consequently, the recent changes have no impact on our ability to serve clients, ensure operational continuity, or pursue our long-term growth objectives. IKS remains committed to its strategy of driving value for clients through deep domain expertise, technology-led solutions, and a robust global delivery framework. We will continue to monitor developments in the global regulatory landscape and provide updates to our stakeholders as necessary. Powered by Capital Market - Live

Inventurus Knowledge Solutions has granted 213,000 employee stock options to certain eligible employee(s) under the IKS ESOP Plan on 05 September 2025.Powered by Capital Market - Live

Inventurus Knowledge Solutions announced that the 19th Annual General Meeting(AGM) of the company will be held on 23 September 2025.Powered by Capital Market - Live

Inventurus Knowledge Solutions has approved grant of 150,000 stock options under the IKS ESOP Plan on 01 September 2025. Powered by Capital Market - Live